NeoGenomics, Inc.

Good day, ladies and gentlemen, and welcome to the Neogenomics Third Quarter 2021 Earnings Call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, CEO Mark Mallon. Sir, the floor is yours.

Thank you, and good morning, everyone. I'd like to welcome you all to the new Neogenomics 2021 third quarter conference call. And I'm very pleased that for the first time, we're all doing this call from our new Fort Myers headquarters. Joining me here are George Cadoza, our Chief Operating Officer and President of Lab Operations, Doug Brown, our Chief Strategy and Corporate Development Officer, and Charlie Edson, our Director of Investor Relations. Joining the call via phone from California is Dr. Gina Waller, President of our Pharma Services Division and from the UK, President of Innovata, Dr. Clyde Morris. Also here with us today are Kathy McKenzie, our CFO, and Bill Bonello, our President of Informatics. Per our press release this morning, we are excited and I'm excited to announce their new role in neogenomics. I want to thank them for important contributions in their current role, and I'm so pleased to have them continue with their new responsibilities as key members of the neogenomics leadership team. Since taking over as CEO of Neogenomics in April, I've been working closely with our board on succession planning and optimizing our leadership team and structure. As a part of this process, we've taken important steps to reorganize internally, including promoting George to head of our lab operations and Dr. Wallace to head of our pharma services. We've also been able to attract world-class talent to our leadership team, hiring Hallie Gilbert as our chief legal officer, John Mooney as our chief technology officer, We have some additional leadership positions to fill, but I'm pleased with the moves we've made and the positive impacts on our business I believe they will have. Before we begin our prepared remarks, Charlie will read the standard language of our forward-looking statements.

This conference call may contain forward-looking statements which represent our current expectations and beliefs about our operations, performance, financial condition, and growth opportunities. Any statements made on this call that are not statements of historical fact are forward-looking statements. These statements, by their nature, involve substantial risks and uncertainties, certain of which are beyond our control. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual outcomes and results could differ materially from those indicated in the forward-looking statement. Any forward-looking statement speaks only as of today, and we undertake no obligation to update any such statements to reflect events or circumstances after today. Before turning the call back to Mark, I want to let everyone know that we'll be making a copy of our prepared remarks for this morning's call available on the investor relations section of our website shortly after the call is completed. We also want to let everyone know that we are going to limit the number of questions to one per person in order to give more people a chance to ask questions within the one hour that has been allotted for this call.